Global Drug based on CAR T-Cell Market Research Report 2024(Status and Outlook)
Report Overview:
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The Global Drug based on CAR T-Cell Market Size was estimated at USD 389.83 million in 2023 and is projected to reach USD 585.03 million by 2029, exhibiting a CAGR of 7.00% during the forecast period.
This report provides a deep insight into the global Drug based on CAR T-Cell market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug based on CAR T-Cell Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug based on CAR T-Cell market in any manner.
Global Drug based on CAR T-Cell Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Market Segmentation (by Type)
CD19-targeted
BCMA-targeted
Market Segmentation (by Application)
Lymphoma
Multiple Myeloma
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug based on CAR T-Cell Market
Overview of the regional outlook of the Drug based on CAR T-Cell Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug based on CAR T-Cell Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Drug based on CAR T-Cell
- 1.2 Key Market Segments
- 1.2.1 Drug based on CAR T-Cell Segment by Type
- 1.2.2 Drug based on CAR T-Cell Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Drug based on CAR T-Cell Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Drug based on CAR T-Cell Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global Drug based on CAR T-Cell Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Drug based on CAR T-Cell Market Competitive Landscape
- 3.1 Global Drug based on CAR T-Cell Sales by Manufacturers (2019-2024)
- 3.2 Global Drug based on CAR T-Cell Revenue Market Share by Manufacturers (2019-2024)
- 3.3 Drug based on CAR T-Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Drug based on CAR T-Cell Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers Drug based on CAR T-Cell Sales Sites, Area Served, Product Type
- 3.6 Drug based on CAR T-Cell Market Competitive Situation and Trends
- 3.6.1 Drug based on CAR T-Cell Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Drug based on CAR T-Cell Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Drug based on CAR T-Cell Industry Chain Analysis
- 4.1 Drug based on CAR T-Cell Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Drug based on CAR T-Cell Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Drug based on CAR T-Cell Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Drug based on CAR T-Cell Sales Market Share by Type (2019-2024)
- 6.3 Global Drug based on CAR T-Cell Market Size Market Share by Type (2019-2024)
- 6.4 Global Drug based on CAR T-Cell Price by Type (2019-2024)
- 7 Drug based on CAR T-Cell Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Drug based on CAR T-Cell Market Sales by Application (2019-2024)
- 7.3 Global Drug based on CAR T-Cell Market Size (M USD) by Application (2019-2024)
- 7.4 Global Drug based on CAR T-Cell Sales Growth Rate by Application (2019-2024)
- 8 Drug based on CAR T-Cell Market Segmentation by Region
- 8.1 Global Drug based on CAR T-Cell Sales by Region
- 8.1.1 Global Drug based on CAR T-Cell Sales by Region
- 8.1.2 Global Drug based on CAR T-Cell Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Drug based on CAR T-Cell Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Drug based on CAR T-Cell Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Drug based on CAR T-Cell Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Drug based on CAR T-Cell Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Drug based on CAR T-Cell Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Novartis
- 9.1.1 Novartis Drug based on CAR T-Cell Basic Information
- 9.1.2 Novartis Drug based on CAR T-Cell Product Overview
- 9.1.3 Novartis Drug based on CAR T-Cell Product Market Performance
- 9.1.4 Novartis Business Overview
- 9.1.5 Novartis Drug based on CAR T-Cell SWOT Analysis
- 9.1.6 Novartis Recent Developments
- 9.2 Gilead Sciences
- 9.2.1 Gilead Sciences Drug based on CAR T-Cell Basic Information
- 9.2.2 Gilead Sciences Drug based on CAR T-Cell Product Overview
- 9.2.3 Gilead Sciences Drug based on CAR T-Cell Product Market Performance
- 9.2.4 Gilead Sciences Business Overview
- 9.2.5 Gilead Sciences Drug based on CAR T-Cell SWOT Analysis
- 9.2.6 Gilead Sciences Recent Developments
- 9.3 Bristol-Myers Squibb
- 9.3.1 Bristol-Myers Squibb Drug based on CAR T-Cell Basic Information
- 9.3.2 Bristol-Myers Squibb Drug based on CAR T-Cell Product Overview
- 9.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Product Market Performance
- 9.3.4 Bristol-Myers Squibb Drug based on CAR T-Cell SWOT Analysis
- 9.3.5 Bristol-Myers Squibb Business Overview
- 9.3.6 Bristol-Myers Squibb Recent Developments
- 9.4 J and J
- 9.4.1 J and J Drug based on CAR T-Cell Basic Information
- 9.4.2 J and J Drug based on CAR T-Cell Product Overview
- 9.4.3 J and J Drug based on CAR T-Cell Product Market Performance
- 9.4.4 J and J Business Overview
- 9.4.5 J and J Recent Developments
- 9.5 JW Therapeutics
- 9.5.1 JW Therapeutics Drug based on CAR T-Cell Basic Information
- 9.5.2 JW Therapeutics Drug based on CAR T-Cell Product Overview
- 9.5.3 JW Therapeutics Drug based on CAR T-Cell Product Market Performance
- 9.5.4 JW Therapeutics Business Overview
- 9.5.5 JW Therapeutics Recent Developments
- 9.6 FOSUNKite
- 9.6.1 FOSUNKite Drug based on CAR T-Cell Basic Information
- 9.6.2 FOSUNKite Drug based on CAR T-Cell Product Overview
- 9.6.3 FOSUNKite Drug based on CAR T-Cell Product Market Performance
- 9.6.4 FOSUNKite Business Overview
- 9.6.5 FOSUNKite Recent Developments
- 9.7 CARsgen Therapeutics (Pipeline)
- 9.7.1 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Basic Information
- 9.7.2 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Overview
- 9.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Market Performance
- 9.7.4 CARsgen Therapeutics (Pipeline) Business Overview
- 9.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
- 9.8 CARsgen Therapeutics
- 9.8.1 CARsgen Therapeutics Drug based on CAR T-Cell Basic Information
- 9.8.2 CARsgen Therapeutics Drug based on CAR T-Cell Product Overview
- 9.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Product Market Performance
- 9.8.4 CARsgen Therapeutics Business Overview
- 9.8.5 CARsgen Therapeutics Recent Developments
- 9.9 Autolus Therapeutics
- 9.9.1 Autolus Therapeutics Drug based on CAR T-Cell Basic Information
- 9.9.2 Autolus Therapeutics Drug based on CAR T-Cell Product Overview
- 9.9.3 Autolus Therapeutics Drug based on CAR T-Cell Product Market Performance
- 9.9.4 Autolus Therapeutics Business Overview
- 9.9.5 Autolus Therapeutics Recent Developments
- 9.10 Sorrento Therapeutics
- 9.10.1 Sorrento Therapeutics Drug based on CAR T-Cell Basic Information
- 9.10.2 Sorrento Therapeutics Drug based on CAR T-Cell Product Overview
- 9.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Product Market Performance
- 9.10.4 Sorrento Therapeutics Business Overview
- 9.10.5 Sorrento Therapeutics Recent Developments
- 9.11 Mustang Bio
- 9.11.1 Mustang Bio Drug based on CAR T-Cell Basic Information
- 9.11.2 Mustang Bio Drug based on CAR T-Cell Product Overview
- 9.11.3 Mustang Bio Drug based on CAR T-Cell Product Market Performance
- 9.11.4 Mustang Bio Business Overview
- 9.11.5 Mustang Bio Recent Developments
- 9.12 Bluebird Bio
- 9.12.1 Bluebird Bio Drug based on CAR T-Cell Basic Information
- 9.12.2 Bluebird Bio Drug based on CAR T-Cell Product Overview
- 9.12.3 Bluebird Bio Drug based on CAR T-Cell Product Market Performance
- 9.12.4 Bluebird Bio Business Overview
- 9.12.5 Bluebird Bio Recent Developments
- 9.13 Cellectis
- 9.13.1 Cellectis Drug based on CAR T-Cell Basic Information
- 9.13.2 Cellectis Drug based on CAR T-Cell Product Overview
- 9.13.3 Cellectis Drug based on CAR T-Cell Product Market Performance
- 9.13.4 Cellectis Business Overview
- 9.13.5 Cellectis Recent Developments
- 9.14 Allogene Therapeutics
- 9.14.1 Allogene Therapeutics Drug based on CAR T-Cell Basic Information
- 9.14.2 Allogene Therapeutics Drug based on CAR T-Cell Product Overview
- 9.14.3 Allogene Therapeutics Drug based on CAR T-Cell Product Market Performance
- 9.14.4 Allogene Therapeutics Business Overview
- 9.14.5 Allogene Therapeutics Recent Developments
- 9.15 Celyad
- 9.15.1 Celyad Drug based on CAR T-Cell Basic Information
- 9.15.2 Celyad Drug based on CAR T-Cell Product Overview
- 9.15.3 Celyad Drug based on CAR T-Cell Product Market Performance
- 9.15.4 Celyad Business Overview
- 9.15.5 Celyad Recent Developments
- 10 Drug based on CAR T-Cell Market Forecast by Region
- 10.1 Global Drug based on CAR T-Cell Market Size Forecast
- 10.2 Global Drug based on CAR T-Cell Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Drug based on CAR T-Cell Market Size Forecast by Country
- 10.2.3 Asia Pacific Drug based on CAR T-Cell Market Size Forecast by Region
- 10.2.4 South America Drug based on CAR T-Cell Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Drug based on CAR T-Cell by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global Drug based on CAR T-Cell Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of Drug based on CAR T-Cell by Type (2025-2030)
- 11.1.2 Global Drug based on CAR T-Cell Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of Drug based on CAR T-Cell by Type (2025-2030)
- 11.2 Global Drug based on CAR T-Cell Market Forecast by Application (2025-2030)
- 11.2.1 Global Drug based on CAR T-Cell Sales (Kilotons) Forecast by Application
- 11.2.2 Global Drug based on CAR T-Cell Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook